Designing novel inhibitors
of epigenetic target — SIRT1

3.2M

focused library screened

94

hit candidates
selected

5

potent compounds
identified

90 nM

IC50 of the best
compound

Type image caption here (optional)

01/ Background

  • The target is Human Silent Mating Type Information Regulation 2 Homolog 1 (SIRT1).
  • SIRT1 deacetylates histones and various other proteins, which are involved in multiple signaling pathways.

02/ Methodology

  • 3.2M compounds were prefiltered from 11M stock library based on
16 psychem/druglike filters.
  • QuorumMap optimization parameters defined by project input.
  • Optimization loop included docking against target and off-targets with ArtiDock and ADME-Tox prediction with ADMTETIQ
  • After 100 cycle runs, optimzation reached a plateau.
  • 94 compounds were selected for in vitro validation.
  • Differential scanning fluorimetry assay performed.

03/ Results

  • 4 compounds demonstrated a significant binding effect.
  • 1 hit compound shown 3x selectivity against off-targets.
  • This hit was subjected to dose-response test in SIRT-Glo assay.
*Difference between SIRT1-control and
SIRT1-ligand complex melting temperatures
*ADMET-PK profile

04/ Best Compound

  • This compound has shown outstanding nanomolar activity
    (IC50 = 90 nM)
    measured by a functional assay based on the release of the fluorophore probe from acetylated p53-AFC.
  • This makes it de facto a lead compound.